A 73-year-old woman underwent open mitral valve replacement with the transcatheter Edwards SAPIEN XT valve (Edwards Lifesciences, Corp, Irvine, CA USA) on cardiopulmonary bypass in a native, stenotic mitral valve. Because of left ventricular outflow tract obstruction, the patient died 25 days after implantation. There are previous reports of transcatheter valve implantation in native mitral valve with procedural success. However, in one case report, the patient died 10 days postoperatively.
CarrelT., WenaweserP., ReinekeS.Worldwide first surgical implantation of a transcatheter valved stent in mitral position. Cardiovasc Med.2012; 15: 202–220.
2.
El-EshmawiA., LoveB., BhattH.V., PawaleA., BoatengP., AdamsD.H.Direct access implantation of a Melody valve in native mitral valve: a hybrid approach in the presence of extensive mitral annular calcification. Ann Thorac Surg.2015; 99: 1085.
3.
GuerreroM., GreenbaumA., O'NeillW.First in human percutaneous implantation of a balloon expandable transcatheter heart valve in a severely stenosed native mitral valve. Catheter Cardiovasc Interv.2014; 83: E287–E291.
4.
BapatV., PironeF., KapetanakisS., RajaniR., NiederelS.Factors influencing left ventricular outflow tract obstruction following a mitral valve-in-valve or valve-in-ring procedure, part 1. Catheter Cardiovasc Interv.2015; 86: 747–760.
5.
MaisanoF., AlfieriO., BanaiS.The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement?Eur Heart J.2015; 36: 1651–1659.
